Advanced search
Publication Cover
Expert Review of Dermatology Volume 8, 2013 - Issue 6
Journal homepage
32
Views
0
CrossRef citations to date
0
Altmetric
Reviews

The epidemiology of melanoma in young adults

Ana I VelazquezMayo Graduate School, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
&
Jerry D BrewerDepartment of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USACorrespondence[email protected]
Pages 707-716 | Published online: 10 Jan 2014

References

  • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 63(1) 11–30 (2013).
  • Erickson C, Driscoll MS. Melanoma epidemic: Facts and controversies. Clin. Dermatol. 28(3) 281–286 (2010).
  • Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J. Invest. Dermatol. 129(7) 1666–1674 (2009).
  • Erdei E, Torres SM. A new understanding in the epidemiology of melanoma. Expert Rev. Anticancer Ther. 10(11) 1811–1823 (2010).
  • De Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int. J. Cancer 107(1) 119–126 (2003).
  • Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J. Natl Cancer Inst. 93(9) 678–683 (2001).
  • Jemal A, Siegel R, Ward E.et al. Cancer statistics, 2006. CA Cancer J. Clin. 56(2) 106–130 (2006).
  • Marks R. Epidemiology of melanoma. Clin. Exp. Dermatol. 25(6) 459–463 (2000).
  • Veierod MB, Weiderpass E, Thorn M et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J. Natl Cancer Inst. 95(20) 1530–1538 (2003).
  • Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. Screening, early detection, and trends for melanoma: current status (2000–2006) and future directions. J. Am. Acad. Dermatol. 57(4) 555–572; quiz 573–556 (2007).
  • Ries LA, Wingo PA, Miller DS et al. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer 88(10) 2398–2424 (2000).
  • Rigel DS. Epidemiology and prognostic factors in malignant melanoma. Ann. Plast. Surg. 28(1) 7–8 (1992).
  • Aben KK, Van Gaal C, Van Gils NA, Van Der Graaf WT, Zielhuis GA. Cancer in adolescents and young adults (15–29 years): a population-based study in the Netherlands 1989–2009. Acta Oncol. 51(7) 922–933 (2012).
  • Bleyer A, Barr R. Cancer in young adults 20 to 39 years of age: overview. Semin. Oncol. 36(3) 194–206 (2009).
  • Reed KB, Brewer JD, Lohse CM, Bringe KE, Pruitt CN, Gibson LE. Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. Mayo Clin. Proc. 87(4) 328–334 (2012).
  • Bleyer A, O’leary M, Barr R, Ries LE. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975–2000. National Cancer Institute, NIH Pub. No. 06–5767, Bethesda, MD (2006).
  • Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J. Photochem. Photobiol. B 63(1–3), 8–18 (2001).
  • Australian Institute of Health and Welfare (AIHW). ACIM (Australian Cancer Incidence and Mortality) Books. AIHW, Canberra (2012).
  • Jemal A, Saraiya M, Patel P et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992–2006. J. Am. Acad. Dermatol. 65(5 Suppl. 1), S17–25 e11–13 (2011).
  • Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, Mcnally RJ. Classification and incidence of cancers in adolescents and young adults in England 1979–1997. Br. J. Cancer 87(11) 1267–1274 (2002).
  • Magnanti BL, Dorak MT, Parker L, Craft AW, James PW, Mcnally RJ. Sex-specific incidence and temporal trends in solid tumours in young people from Northern England, 1968–2005. BMC Cancer 8, 89 (2008).
  • Forsea AM, Del Marmol V, De Vries E, Bailey EE, Geller AC. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br. J. Dermatol. 167(5) 1124–1130 (2012).
  • Purdue MP, Freeman LE, Anderson WF, Tucker MA. Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J. Invest. Dermatol. 128(12) 2905–2908 (2008).
  • Weir HK, Marrett LD, Cokkinides V et al. Melanoma in adolescents and young adults (ages 15–39 years): United States, 1999–2006. J. Am. Acad. Dermatol. 65(5 Suppl. 1), S38–49 (2011).
  • Bleyer A, Viny A, Barr R. Cancer in 15- to 29-year-olds by primary site. Oncologist 11(6) 590–601 (2006).
  • La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int. J. Cancer 81(1) 62–66 (1999).
  • Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br. J. Dermatol. 150(2) 179–185 (2004).
  • Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br. J. Cancer 82(11) 1887–1891 (2000).
  • American Cancer Society (ACS). Cancer Facts & Figures 2013. American Cancer Society, Atlanta (2013).
  • Austin PF, Cruse CW, Lyman G, Schroer K, Glass F, Reintgen DS. Age as a prognostic factor in the malignant melanoma population. Ann. Surg. Oncol. 1(6) 487–494 (1994).
  • Balch CM, Soong SJ, Gershenwald JE et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 19(16) 3622–3634 (2001).
  • Chagpar RB, Ross MI, Reintgen DS et al. Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. J. Surg. Res. 143(1) 164–168 (2007).
  • Cinar P, Zell JA, Taylor TH, Sender LS, Anton-Culver H. Pediatric and AYA invasive cutaneous melanoma: population-based study comparing adult melanoma cases. J. Clin. Oncol. 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition) 26(15S), 9071 (2008).
  • Shaw HM, Milton GW, Farago G, Mccarthy WH. Endocrine influences on survival from malignant melanoma. Cancer 42(2) 669–677 (1978).
  • Stidham KR, Johnson JL, Seigler HF. Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. Arch. Surg. 129(3) 316–324 (1994).
  • Thorn M, Adami HO, Ringborg U, Bergstrom R, Krusemo UB. Long-term survival in malignant melanoma with special reference to age and sex as prognostic factors. J. Natl Cancer Inst .79(5) 969–974 (1987).
  • Lee JA, Strickland D. Malignant melanoma: social status and outdoor work. Br. J. Cancer 41(5) 757–763 (1980).
  • Liu F, Bessonova L, Taylor TH, Ziogas A, Meyskens FL, Jr., Anton-Culver H. A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important. Pigment Cell Melanoma. Res. 26(1) 128–135 (2013).
  • Desandes E, Lacour B, Belot A et al. Cancer Incidence and Survival in Adolescents and Young Adults in France, 2000–2008. Pediatr. Hematol. Oncol. (2013).
  • Wu X, Groves FD, Mclaughlin CC, Jemal A, Martin J, Chen VW. Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control 16(3) 309–320 (2005).
  • Bradford PT, Anderson WF, Purdue MP, Goldstein AM, Tucker MA. Rising melanoma incidence rates of the trunk among younger women in the United States. Cancer Epidemiol. Biomarkers Prev. 19(9) 2401–2406 (2010).
  • Wu XC, Eide MJ, King J et al. Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999–2006. J. Am. Acad. Dermatol. 65(5 Suppl. 1), S26–S37 (2011).
  • Kemeny MM, Busch E, Stewart AK, Menck HR. Superior survival of young women with malignant melanoma. Am. J. Surg. 175(6) 437–444; discussion 444–435 (1998).
  • Chao C, Martin RC 2nd, Ross MI et al. Correlation between prognostic factors and increasing age in melanoma. Ann. Surg. Oncol. 11(3) 259–264 (2004).
  • Mcmasters KM, Noyes RD, Reintgen DS et al. Lessons learned from the Sunbelt Melanoma Trial. J. Surg. Oncol. 86(4) 212–223 (2004).
  • Scolyer RA, Long GV, Thompson JF. Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Mol. Oncol. 5(2) 124–136 (2011).
  • Markovic SN, Erickson LA, Rao RD et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin. Proc. 82(3) 364–380 (2007).
  • Cho YR, Chiang MP. Epidemiology, staging (new system), and prognosis of cutaneous melanoma. Clin. Plast. Surg. 37(1) 47–53 (2010).
  • Balch CM, Gershenwald JE, Soong SJ et al. Final version of 2009 AJCC Melanoma Staging and Classification. J. Clin. Oncol. 27(36) 6199–6206 (2009).
  • Elwood JM, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int. J. Cancer 78(3) 276–280 (1998).
  • Curtin JA, Fridlyand J, Kageshita T et al. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353(20) 2135–2147 (2005).
  • Clark LN, Shin DB, Troxel AB, Khan S, Sober AJ, Ming ME. Association between the anatomic distribution of melanoma and sex. J. Am. Acad. Dermatol. 56(5) 768–773 (2007).
  • Elwood JM, Gallagher RP, Hill GB, Pearson JC. Cutaneous melanoma in relation to intermittent and constant sun exposure–the Western Canada Melanoma Study. Int. J. Cancer 35(4) 427–433 (1985).
  • Elwood JM, Lee JA. Recent data on the epidemiology of malignant melanoma. Semin. Oncol. 2(2) 149–154 (1975).
  • Green A, Maclennan R, Youl P, Martin N. Site distribution of cutaneous melanoma in Queensland. Int. J. Cancer 53(2) 232–236 (1993).
  • Houghton A, Flannery J, Viola MV. Malignant melanoma in Connecticut and Denmark. Int. J. Cancer 25(1) 95–104 (1980).
  • Kojo K, Jansen CT, Nybom P et al. Population exposure to ultraviolet radiation in Finland 1920–1995: Exposure trends and a time-series analysis of exposure and cutaneous melanoma incidence. Environ. Res. 101(1) 123–131 (2006).
  • Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv. 19–20, 219–240 (1994).
  • Perez-Gomez B, Aragones N, Gustavsson P, Lope V, Lopez-Abente G, Pollan M. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women. Br. J. Dermatol. 158(4) 766–772 (2008).
  • Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur. J. Cancer 41(14) 2040–2059 (2005).
  • Tadokoro T, Yamaguchi Y, Batzer J et al. Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation. J. Invest. Dermatol. 124(6) 1326–1332 (2005).
  • Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature 445(7130) 843–850 (2007).
  • Naldi L, Altieri A, Imberti GL, Giordano L, Gallus S, La Vecchia C. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann. Epidemiol. 15(7) 545–550 (2005).
  • Titus-Ernstoff L, Perry AE, Spencer SK, Gibson JJ, Cole BF, Ernstoff MS. Pigmentary characteristics and moles in relation to melanoma risk. Int. J. Cancer 116(1) 144–149 (2005).
  • Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am. J. Epidemiol. 141(10) 934–942 (1995).
  • Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am. J. Epidemiol. 141(10) 923–933 (1995).
  • Rees JL. The genetics of sun sensitivity in humans. Am. J. Hum. Genet. 75(5) 739–751 (2004).
  • Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H. Cutaneous melanomas associated with nevi. Arch. Dermatol. 139(12) 1620–1624; discussion 1624 (2003).
  • Goldstein AM, Tucker MA. Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr. Opin. Oncol. 5(2) 358–363 (1993).
  • Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J. Am. Acad. Dermatol. 17(3) 459–468 (1987).
  • Garbe C, Buttner P, Weiss J et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J. Invest. Dermatol. 102(5) 700–705 (1994).
  • Tucker MA, Halpern A, Holly EA et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 277(18) 1439–1444 (1997).
  • Swerdlow AJ, English J, Mackie RM et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br. Med. J. (Clin. Res. Ed.) 292(6535) 1555–1559 (1986).
  • Garbe C, Buttner P, Weiss J et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J. Invest. Dermatol. 102(5) 695–699 (1994).
  • Naldi L, Lorenzo Imberti G, Parazzini F, Gallus S, La Vecchia C. Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer 88(12) 2703–2710 (2000).
  • Watt AJ, Kotsis SV, Chung KC. Risk of melanoma arising in large congenital melanocytic nevi: a systematic review. Plast. Reconstr. Surg. 113(7) 1968–1974 (2004).
  • Purdue MP, From L, Armstrong BK et al. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma. Cancer Epidemiol. Biomarkers Prev. 14(8) 2015–2022 (2005).
  • Cho E, Rosner BA, Colditz GA. Risk factors for melanoma by body site. Cancer Epidemiol. Biomarkers Prev. 14(5) 1241–1244 (2005).
  • Cho E, Rosner BA, Feskanich D, Colditz GA. Risk factors and individual probabilities of melanoma for whites. J. Clin. Oncol. 23(12) 2669–2675 (2005).
  • Ford D, Bliss JM, Swerdlow AJ et al. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int. J. Cancer 62(4) 377–381 (1995).
  • Hemminki K, Zhang H, Czene K. Familial and attributable risks in cutaneous melanoma: effects of proband and age. J. Invest. Dermatol. 120(2) 217–223 (2003).
  • Ferrone CR, Ben Porat L, Panageas KS et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 294(13) 1647–1654 (2005).
  • Marghoob AA, Slade J, Salopek TG, Kopf AW, Bart RS, Rigel DS. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications. Cancer 75(2 Suppl.), 707–714 (1995).
  • Meyer LJ, Zone JH. Genetics of cutaneous melanoma. J. Invest. Dermatol. 103(5 Suppl.), 112S–116S (1994).
  • Bishop DT, Demenais F, Goldstein AM et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl Cancer Inst. 94(12) 894–903 (2002).
  • Tsao H, Niendorf K. Genetic testing in hereditary melanoma. J. Am. Acad. Dermatol. 51(5) 803–808 (2004).
  • Newton Bishop JA, Harland M, Bishop DT. The genetics of melanoma: the UK experience. Clin. Exp. Dermatol. 23(4) 158–161 (1998).
  • Titus-Ernstoff L, Perry AE, Spencer SK et al. Multiple primary melanoma: two-year results from a population-based study. Arch. Dermatol. 142(4) 433–438 (2006).
  • Reyes-Ortiz CA, Goodwin JS, Freeman JL. The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma. Med. Sci. Monit. 11(5) RA163–172 (2005).
  • Kirkpatrick CS, Lee JA, White E. Melanoma risk by age and socio-economic status. Int. J. Cancer 46(1) 1–4 (1990).
  • Mackie RM, Bray CA. Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma. Br. J. Cancer 90(4) 770–772 (2004).
  • Krieger N, Quesenberry C Jr, Peng T et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988–92 (United States). Cancer Causes Control 10(6) 525–537 (1999).
  • Clegg LX, Reichman ME, Miller BA et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 20(4) 417–435 (2009).
  • Harrison RA, Haque AU, Roseman JM, Soong SJ. Socioeconomic characteristics and melanoma incidence. Annals of Epidemiology 8(5) 327–333 (1998).
  • Elwood JM, Whitehead SM, Davison J, Stewart M, Galt M. Malignant melanoma in England: risks associated with naevi, freckles, socialclass, hair colour, and sunburn. Int. J. Epidemiol. 19(4) 801–810 (1990).
  • Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N. Engl. J. Med. 340(17) 1341–1348 (1999).
  • Katsambas A, Nicolaidou E. Cutaneous malignant melanoma and sun exposure. Recent developments in epidemiology. Arch. Dermatol. 132(4) 444–450 (1996).
  • Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res. 3(6) 395–401 (1993).
  • Berwick M, Halpern A. Melanoma epidemiology. Curr. Opin. Oncol. 9(2) 178–182 (1997).
  • Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int. J. Cancer 73(2) 198–203 (1997).
  • Lew RA, Sober AJ, Cook N, Marvell R, Fitzpatrick TB. Sun exposure habits in patients with cutaneous melanoma: a case control study. J. Dermatol. Surg. Oncol. 9(12) 981–986 (1983).
  • Westerdahl J, Olsson H, Ingvar C. At what age do sunburn episodes play a crucial role for the development of malignant melanoma. Eur. J. Cancer 30A(11), 1647–1654 (1994).
  • International Agency for Research on Cancer (IARC). IARC Working Group Reports - Exposure to artificial UV radiation and skin cancer. IARC Working Group Reports - Exposure to artificial UV radiation and skin cancer (2006a).
  • International Agency for Research on Cancer (IARC). The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int. J. Cancer. 120(5) 1116–1122 (2007).
  • Hoerster KD, Garrow RL, Mayer JA et al. Density of indoor tanning facilities in 116 large U.S. cities. Am. J. Prev. Med. 36(3) 243–246 (2009).
  • Levine JA, Sorace M, Spencer J, Siegel DM. The indoor UV tanning industry: a review of skin cancer risk, health benefit claims, and regulation. J. Am. Acad. Dermatol. 53(6) 1038–1044 (2005).
  • Eaton DK, Kann L, Kinchen S et al. Youth risk behavior surveillance - United States, 2011. MMWR Surveill. Summ. 61(4) 1–162 (2012).
  • Mackie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann. Oncol. 20 (Suppl. 6), vi1–7 (2009).
  • Centers for Disease Control and Prevention (CDC). Use of indoor tanning devices by adults–United States, 2010. MMWR Morb. Mortal. Wkly. Rep. 61(18) 323–326 (2012).
  • Lazovich D, Sweeney C, Forster J. Prevalence of indoor tanning use in Minnesota, 2002. Arch. Dermatol. 141(4) 523–524 (2005).
  • Autier P. Perspectives in melanoma prevention: the case of sunbeds. European Journal of Cancer 40(16) 2367–2376 (2004).
  • Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 345, e4757 (2012).
  • El Ghissassi F, Baan R, Straif K et al. A review of human carcinogens–part D: radiation. Lancet Oncol. 10(8) 751–752. (2009).
  • Autier P, Boniol M, Severi G, Pedeux R, Grivegnee AR, Dore JF. Sex differences in numbers of nevi on body sites of young European children: implications for the etiology of cutaneous melanoma. Cancer Epidemiol. Biomarkers Prev. 13(12) 2003–2005 (2004).
  • Lazovich D, Vogel RI, Berwick M, Weinstock MA, Anderson KE, Warshaw EM. Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol. Biomarkers Prev. 19(6) 1557–1568 (2010).
  • International Agency for Research on Cancer (IARC). Radiation. IARC Monogr. Eval. Carcinog. Risks Hum. 100(Pt D), 7–303 (2012).
  • Hirst N, Gordon L, Gies P, Green AC. Estimation of avoidable skin cancers and cost-savings to government associated with regulation of the solarium industry in Australia. Health Policy 89(3) 303–311 (2009).
  • Gordon LG, Hirst NG, Gies PH, Green AC. What impact would effective solarium regulation have in Australia? Med. J. Aust.189(7) 375–378 (2008).
  • Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol. Biomarkers Prev. 14(3) 562–566 (2005).
  • Hery C, Tryggvadottir L, Sigurdsson T et al. A melanoma epidemic in Iceland: possible influence of sunbed use. Am. J. Epidemiol. 172(7) 762–767 (2010).
  • Cust AE, Armstrong BK, Goumas C et al. Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int. J. Cancer 128(10) 2425–2435 (2011).
  • Hausauer AK, Swetter SM, Cockburn MG, Clarke CA. Increases in melanoma among adolescent girls and young women in California: trends by socioeconomic status and UV radiation exposure. Arch. Dermatol. 147(7) 783–789 (2011).
  • Boynton A, Oxlad M. Melanoma and its relationship with solarium use: health knowledge, attitudes and behaviour of young women. J. Health Psychol. 16(6) 969–979 (2011).
  • Gosis B, Sampson BP, Seidenberg AB, Balk SJ, Gottlieb M, Geller AC. Comprehensive evaluation of indoor tanning regulations: a 50-state analysis, 2012. j. invest. dermatol. (2013) (Epub ahead of print).
  • Pawlak MT, Bui M, Amir M, Burkhardt DL, Chen AK, Dellavalle RP. Legislation restricting access to indoor tanning throughout the world. Arch. Dermatol. 148(9) 1006–1012 (2012).

Websites

  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer (2010). http://globocan.iarc.fr (Accessed on 3 May 2013)
  • Howlader N, Noone AM, Krapcho M (Eds). SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, USA (based on November 2012 SEER data submission, posted to the SEER website in April 2013). http://seer.cancer.gov/csr/1975_2010/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.